Turtle Creek Wealth Advisors, LLC

Position in MRK — Merck & Co., Inc.

CIK 2007171 DALLAS, TX

Position in MRK

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$3,722,388

+$504,270 QoQ

Shares Held

28,968

+8.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#1,197

of 3,769 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Turtle Creek Wealth Advisors, LLC holds $73,913,810 across 10 Drug Manufacturers - General names. MRK ranks #5 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	27,818	$33,365,746
2	JNJ	Johnson & Johnson	60,278	$15,308,803
3	AZN	Astrazeneca PLC	38,731	$7,344,172
4	ABBV	AbbVie Inc.	28,533	$7,180,044
5	MRK	Merck & Co., Inc. This page	28,968	$3,722,388
6	AMGN	Amgen Inc	9,709	$3,515,823
7	GILD	Gilead Sciences, Inc.	13,235	$1,672,109
8	PFE	Pfizer Inc	36,870	$887,829

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,722,388	28,968	+8.3%	Shares	Sole	2026-07-27
2026-03-31	$3,218,118	26,753	+29.0%	Shares	Sole	2026-04-27
2025-12-31	$2,182,460	20,734	+36.1%	Shares	Sole	2026-01-28
2025-09-30	$1,278,169	15,229	-68.1%	Shares	Sole	2025-10-29
2025-06-30	$3,784,877	47,813	+18.1%	Shares	Sole	2025-07-28
2025-03-31	$3,633,305	40,478	+39.5%	Shares	Sole	2025-05-01
2024-12-31	$2,887,307	29,024	-17.1%	Shares	Sole	2025-01-23
2024-09-30	$3,974,259	34,997	+4.5%	Shares	Sole	2024-11-06
2024-06-30	$4,146,309	33,492	+27.1%	Shares	Sole	2024-07-31
2024-03-31	$3,477,146	26,352	+21.8%	Shares	Sole	2024-04-30
2023-12-31	$2,359,628	21,644	—	Shares	Sole	2024-01-26
No filing history on record for this holder in this stock.